Inspire Medical Systems Inc INSP

$68.86 -2.63 (-3.68%)

Valuation

Market cap: 2,066,775,000
Revenue TTM: $911,980,000
Net income TTM: $145,420,000
PE ratio: 30.35
Forward PE: 55.43
Profit margin: 15.95%
Debt to equity: 0.00

Trading

Volume: 1,040,000
Avg volume: 804,980
Day's range: $68.62 – $72.46
Shares out: 28,910,000
Stochastic %K: 30%
Beta: 0.73
Analysts: Sell
Price target: $65.35

Price

Company profile

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Industry: Medical Devices
Sector: Healthcare
Phone: 844 672 4357
Website: https://www.inspiresleep.com
Address: 5500 Wayzata Blvd., Suite 1600, Golden Valley, United States

Latest news

2026-10-13T11:30:54.000Z · 17 hours ago

Inspire Medical price target raised to $75 from $65 at Mizuho

2026-10-06T20:32:15.000Z · 7 days ago

Inspire Medical initiated with an Underweight at Barclays

Oct 5, 2026, 4:05 PM EDT · 8 days ago

Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026

2026-10-01T20:11:04.000Z · 12 days ago

Inspire Medical announces approval of new CPT codes by AMA panel

Oct 1, 2026, 4:03 PM EDT · 12 days ago

Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel

2026-10-01T11:50:44.000Z · 12 days ago

Inspire Medical price target raised to $75 from $60 at RBC Capital

2026-09-21T10:15:25.000Z · 22 days ago

Inspire Medical price target raised to $97 from $71 at Freedom Broker

2026-09-11T10:30:14.000Z · 4 weeks ago

Inspire Medical price target raised to $80 from $75 at Stifel

Aug 26, 2026, 9:15 AM EDT · 6 weeks ago

Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

2026-08-04T12:42:43.000Z · 2 months ago

Inspire Medical price target raised to $60 from $54 at JPMorgan

2026-08-04T12:16:47.000Z · 2 months ago

Inspire Medical price target raised to $65 from $55 at Mizuho

2026-08-04T12:01:00.000Z · 2 months ago

Inspire Medical price target raised to $54 from $40 at Evercore ISI

2026-08-04T11:35:27.000Z · 2 months ago

Inspire Medical price target raised to $45 from $39 at BofA

2026-08-04T11:35:18.000Z · 2 months ago

Inspire Medical price target raised to $62 from $54 at Truist

2026-08-04T11:02:00.000Z · 2 months ago

Inspire Medical price target raised to $75 from $65 at Stifel

2026-08-04T11:01:50.000Z · 2 months ago

Oppenheimer tactically upgrades Inspire Medical despite noisy fundamentals

2026-08-04T10:55:57.000Z · 2 months ago

Inspire Medical upgraded to Outperform from Perform at Oppenheimer

2026-08-04T10:50:18.000Z · 2 months ago

Inspire Medical price target raised to $60 from $55 at Piper Sandler

2026-08-04T10:20:34.000Z · 2 months ago

Inspire Medical price target raised to $59 from $54 at Baird

Aug 3, 2026, 4:02 PM EDT · 2 months ago

Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan

Jul 27, 2026, 8:00 AM EDT · 2 months ago

Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors

Jul 24, 2026, 5:55 PM EDT · 2 months ago

Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP

Jul 22, 2026, 8:00 AM EDT · 2 months ago

Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors

Jul 6, 2026, 9:48 AM EDT · 3 months ago

Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026

Jul 6, 2026, 8:00 AM EDT · 3 months ago

Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026

Jun 16, 2026, 8:00 AM EDT · 3 months ago

Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study

Jun 12, 2026, 8:00 AM EDT · 4 months ago

Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight

May 4, 2026, 4:02 PM EDT · 5 months ago

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

Apr 29, 2026, 8:00 AM EDT · 5 months ago

Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference

Apr 6, 2026, 8:00 AM EDT · 6 months ago

Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026

Mar 3, 2026, 8:00 AM EST · 7 months ago

Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum

Mar 2, 2026, 12:39 PM EST · 7 months ago

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

Feb 11, 2026, 4:02 PM EST · 8 months ago

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

Jan 22, 2026, 3:36 PM EST · 8 months ago

The Law Offices of Frank R. Cruz Announces Investigation of Inspire Medical Systems, Inc. (INSP) on Behalf of Investors

Jan 13, 2026, 9:00 AM EST · 9 months ago

Impulse Dynamics® Announces New Chief Financial Officer

Jan 12, 2026, 6:45 AM EST · 9 months ago

Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance

Jan 7, 2026, 8:00 AM EST · 9 months ago

Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026

Dec 29, 2025, 9:05 AM EST · 9 months ago

INSP LAWSUIT: Did Inspire Medical Systems, Inc. Mislead Investors? Contact BFA Law by January 5 Legal Deadline if You Suffered Losses

Dec 29, 2025, 8:00 AM EST · 9 months ago

Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 28, 2025, 6:36 AM EST · 9 months ago

INSP REMINDER: Inspire Medical Systems, Inc. Investors are Alerted of the Imminent January 5 Deadline and to Contact BFA Law if You Lost Money

Dec 26, 2025, 8:36 AM EST · 9 months ago

Inspire Medical Systems, Inc. (INSP) Investors are Notified that Company has been Sued for Securities Fraud after 32% Stock Drop and are Urged to Contact BFA Law

Dec 25, 2025, 9:30 AM EST · 9 months ago

INSP INVESTOR LOSSES: Inspire Medical Systems, Inc. Investors May have been Affected by Fraud – Contact BFA Law by January 5 to Protect Your Rights

Dec 21, 2025, 6:45 AM EST · 9 months ago

INSP COURT REMINDER: Inspire Medical Systems, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before January 5

Dec 19, 2025, 7:07 AM EST · 9 months ago

INSP LEGAL NOTICE: Lose Money on Inspire Medical Systems, Inc.? You may have been Affected by Fraud and are Urged to Contact BFA Law by January 5 Deadline

Dec 5, 2025, 8:18 AM EST · 10 months ago

Inspire Medical Systems, Inc. (INSP) Investors are Encouraged to Act before the Upcoming January 5 Securities Fraud Deadline – Contact BFA Law if You Lost Money

Dec 3, 2025, 7:46 AM EST · 10 months ago

INSP NEWS: Inspire Medical Systems, Inc. Sued for Securities Fraud after Stock Plummets 32% -- Investors Notified to Contact BFA Law by January 5 Deadline

Stocktwits

abira Oct 12, 8:22 PM

$MYO hired Ms. Katie McClure from Inspire Medical Systems ($INSP) as the new Chief Commercial Officer. During McClure’s eight-year tenure at Inspire Medical, company-wide revenues scaled from ~$50 million to nearly $1 billion.

0 replies